OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune cellular components and signaling pathways in the tumor microenvironment
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 187-201
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110

Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology
Zhe Wang, Yang Liu, Xing Niu
Seminars in Cancer Biology (2023) Vol. 93, pp. 83-96
Closed Access | Times Cited: 45

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
Betul Ibis, Konstantinos Aliazis, Carol Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40

Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 38

Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer
Junyu Li, Lin Li, Peimeng You, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 35-49
Closed Access | Times Cited: 29

Innovative landscapes in intraperitoneal therapy of ovarian cancer
K. Kumar, M. S. Madhusoodanan, Meghna Pangath, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1

A POSS-Based Metal-Phenolic Network with Coupled Hardness and Softness for Photodynamic-Immunotherapy of Triple-Negative Breast Cancer
Wei Wang, Luanfeng Liao, Yun Huang, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 6, pp. 2369-2380
Closed Access | Times Cited: 7

Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
Yanru Long, Houhui Shi, Yuedong He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6

New insights into the role of complement system in colorectal cancer (Review)
Yu‐wen Xu, Jiaqi Zhou, Yuanyuan Wu, et al.
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Open Access

Nab-Paclitaxel Promotes Radiosensitization by Inducing DNA Damage and Inhibiting Macrophage M2 Polarization in Cholangiocarcinoma
Ningyu Wang, Xiangping Mei, Yang Cao, et al.
Cancer Biotherapy and Radiopharmaceuticals (2025)
Closed Access

Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer
Xue Liang, Ruo-Fei Tian, Ting Li, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

Research into the characteristic molecules significantly affecting liver cancer immunotherapy
Junhong Chen, Hengwei Jin, Hao Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Acidity-induced ITGB6 promote migration and invasion of lung cancer cells by epithelial-mesenchymal transition and focal adhesion
Linxin Liu, Zhuoru He, Zhangyu Jiang, et al.
Experimental Cell Research (2024) Vol. 436, Iss. 1, pp. 113962-113962
Closed Access | Times Cited: 2

ZDHHC9 promotes colon tumor growth by inhibiting effector T cells
Xiaodan Chong, Lingxi Zhu, Yu Dong, et al.
Oncology Letters (2022) Vol. 25, Iss. 1
Open Access | Times Cited: 10

Immune Features of Tumor Microenvironment: A Genetic Spotlight
Milad Asadi, Habib Zarredar, Venus Zafari, et al.
Cell Biochemistry and Biophysics (2023) Vol. 82, Iss. 1, pp. 107-118
Closed Access | Times Cited: 6

Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types
Bingjie Guo, Yajing Wang, Wenyu Liu, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 535-554
Closed Access | Times Cited: 9

Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?
Jiaqiang Wang, Hong Ge, Zhichao Tian
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 385-397
Open Access | Times Cited: 4

TIME Is Critical for Oncolytic Viral Therapies Against Solid Cancers
Vijay Kumar, John H. Stewart
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1

Unveiling the nexus: The tumor microenvironment as a strategic frontier in viral cancers
Queenie Fernandes, Oginni Gbenga Folorunsho
Cytokine (2024) Vol. 185, pp. 156827-156827
Open Access | Times Cited: 1

GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma
Tengling Luo, Junwei Peng, Qijun Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13740-13740
Open Access | Times Cited: 7

A Systematic Immune and Prognostic Analysis of CD48 Interaction with Tumor Microenvironment in Pan-Cancer
Mingdong He, Jun Yu, Shaohua Chen, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 5255-5269
Open Access | Times Cited: 2

Tumor-associated CD8+T cell tolerance induced by erythroid progenitor cells
Xue Fan, Han Peng, Xuesong Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top